ArticleCancers2023

Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.

Lars Tramsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.